IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cousins, S. W.
Right arrow Articles by Streilein, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cousins, S. W.
Right arrow Articles by Streilein, J. W.

Investigative Ophthalmology & Visual Science, Vol 32, 2201-2211, Copyright © 1991 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor

SW Cousins, MM McCabe, D Danielpour and JW Streilein
Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida.

The anterior chamber of the eye is an immunologically privileged site. Over the past 15 years, numerous laboratories documented that the privileged status of this unique site is mediated by multifactorial immunoregulatory processes. Among the participating factors is the aqueous humor that circulates in the anterior chamber and is in contact with most of the tissues in the anterior segment of the eye. Recently, it was found that normal aqueous humor is a powerful inhibitor of antigen-driven T lymphocyte activation, but it spares other important functional properties of T cells. The spectrum of immune inhibitory properties resembles some of the activities of transforming growth factor-beta (TGF-beta), a polypeptide cytokine. Because of this similarity, the authors tried to determine if TGF-beta is present in aqueous humor and whether this cytokine could account for the lymphocyte inhibitory activity of this biologic fluid. They found TGF- beta in aqueous humor by dot-blot analysis. Using the CCL-64 mink lung epithelial cell bioassay for this compound, TGF-beta bioactivity was shown in aqueous humor from several different species, including human. In rabbit and human aqueous humor, most of the biologic activity was due to TGF-beta 2 (80-90%). Dose-response curves generated by using purified porcine TGF-beta showed that aqueous humor contained sufficient concentrations of TGF-beta to account for the observed inhibition in several assays for T cell activation and proliferation. Partial purification of the lymphocyte inhibitor in rabbit aqueous humor by size exclusion in high-performance liquid chromatography demonstrated that several lymphocyte inhibitory fractions contained TGF- beta bioactivity. Finally, neutralizing antisera to TGF-beta 2 were able to reverse most of the lymphocyte inhibitory activity of aqueous humor. It was concluded that TGF-beta was present in high concentration in normal aqueous humor and that this cytokine contributed to the immunosuppressive properties of aqueous humor.


This article has been cited by other articles:


Home page
 IOVSHome page
Y. Ke, G. Jiang, D. Sun, H. J. Kaplan, and H. Shao
Ocular Regulatory T Cells Distinguish Monophasic from Recurrent Autoimmune Uveitis
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3999 - 4007.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. Yang, P. W. Chen, H. Li, H. Alizadeh, and J. Y. Niederkorn
PD-L1: PD-1 Interaction Contributes to the Functional Suppression of T-Cell Responses to Human Uveal Melanoma Cells In Vitro
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2518 - 2525.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Sugita, H. Takase, C. Taguchi, and M. Mochizuki
The Role of Soluble TNF Receptors for TNF-{alpha} in Uveitis
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3246 - 3252.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
L. Shen, S. Barabino, A. W. Taylor, and M. R. Dana
Effect of the Ocular Microenvironment in Regulating Corneal Dendritic Cell Maturation
Arch Ophthalmol, July 1, 2007; 125(7): 908 - 915.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
N. Ohba, K. Nakao, Y. Isashiki, and A. Ohba
The 100 Most Frequently Cited Articles in Ophthalmology Journals
Arch Ophthalmol, July 1, 2007; 125(7): 952 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. Stein-Streilein and A. W. Taylor
An eye's view of T regulatory cells
J. Leukoc. Biol., March 1, 2007; 81(3): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. Fuchshofer, A. H. L. Yu, U. Welge-Lussen, and E. R. Tamm
Bone Morphogenetic Protein-7 Is an Antagonist of Transforming Growth Factor-{beta}2 in Human Trabecular Meshwork Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 715 - 726.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
K. G.-J. Ooi, G. Galatowicz, V. L. Calder, and S. L. Lightman
Cytokines and Chemokines in Uveitis - Is there a Correlation with Clinical Phenotype?
Clin. Med. Res., December 1, 2006; 4(4): 294 - 309.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Banh, P. A. Deschamps, J. Gauldie, P. A. Overbeek, J. G. Sivak, and J. A. West-Mays
Lens-Specific Expression of TGF-{beta} Induces Anterior Subcapsular Cataract Formation in the Absence of Smad3.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3450 - 3460.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Keino, S. Masli, S. Sasaki, J. W. Streilein, and J. Stein-Streilein
CD8+ T Regulatory Cells Use a Novel Genetic Program that Includes CD103 to Suppress Th1 Immunity in Eye-Derived Tolerance.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1533 - 1542.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sugita, T. F. Ng, P. J. Lucas, R. E. Gress, and J. W. Streilein
B7+ Iris Pigment Epithelium Induce CD8+ T Regulatory Cells; Both Suppress CTLA-4+ T Cells
J. Immunol., January 1, 2006; 176(1): 118 - 127.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Lois, J. Taylor, A. D. McKinnon, G. C. Smith, R. van't Hof, and J. V. Forrester
Effect of TGF-{beta}2 and Anti-TGF-{beta}2 Antibody in a New In Vivo Rodent Model of Posterior Capsule Opacification
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4260 - 4266.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
S Rodriguez-Martinez, M E Cancino-Diaz, L Jimenez-Zamudio, E Garcia-Latorre, and J C Cancino-Diaz
TLRs and NODs mRNA expression pattern in healthy mouse eye
Br. J. Ophthalmol., July 1, 2005; 89(7): 904 - 910.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
H.-H. Lin, D. E. Faunce, M. Stacey, A. Terajewicz, T. Nakamura, J. Zhang-Hoover, M. Kerley, M. L. Mucenski, S. Gordon, and J. Stein-Streilein
The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance
J. Exp. Med., May 16, 2005; 201(10): 1615 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
R. Tsukahara, M. Takeuchi, H. Akiba, T. Kezuka, K. Takeda, Y. Usui, M. Usui, H. Yagita, and K. Okumura
Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation
Int. Immunol., May 1, 2005; 17(5): 523 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
N. Kitaichi, K. Namba, and A. W. Taylor
Inducible immune regulation following autoimmune disease in the immune-privileged eye
J. Leukoc. Biol., April 1, 2005; 77(4): 496 - 502.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. Zamiri, S. Masli, N. Kitaichi, A. W. Taylor, and J. W. Streilein
Thrombospondin Plays a Vital Role in the Immune Privilege of the Eye
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 908 - 919.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
H. Keino, T. Kezuka, M. Takeuchi, N. Yamakawa, T. Hattori, and M. Usui
Prevention of Experimental Autoimmune Uveoretinitis by Vasoactive Intestinal Peptide
Arch Ophthalmol, August 1, 2004; 122(8): 1179 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Kezuka, M. Takeuchi, H. Keino, Y. Usui, A. Takeuchi, N. Yamakawa, and M. Usui
Peritoneal Exudate Cells Treated with Calcitonin Gene-Related Peptide Suppress Murine Experimental Autoimmune Uveoretinitis via IL-10
J. Immunol., July 15, 2004; 173(2): 1454 - 1462.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. A. Dullforce, K. L. Garman, G. W. Seitz, R. J. Fleischmann, S. M. Crespo, S. R. Planck, D. C. Parker, and J. T. Rosenbaum
APCs in the Anterior Uveal Tract Do Not Migrate to Draining Lymph Nodes
J. Immunol., June 1, 2004; 172(11): 6701 - 6708.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. M. Kosiewicz, P. Alard, S. Liang, and S. L Clark
Mechanisms of tolerance induced by transforming growth factor-{beta}-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand
Int. Immunol., May 1, 2004; 16(5): 697 - 706.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Yamagami, S. Yokoo, T. Mimura, and S. Amano
Effects of TGF-{beta}2 on Immune Response-Related Gene Expression Profiles in the Human Corneal Endothelium
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 515 - 521.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. E. Skelsey, E. Mayhew, and J. Y. Niederkorn
Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5242 - 5251.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Xu, P. B. Silver, T. K. Tarrant, C.-C. Chan, and R. R. Caspi
TGF-{beta} Inhibits Activation and Uveitogenicity of Primary but Not of Fully Polarized Retinal Antigen-Specific Memory-Effector T Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4805 - 4812.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. A. Rezai, L. Farrokh-Siar, E. M. Gasyna, J. T. Ernest, and G. A. van Seventer
The Effect of Type I and II Interferons on Human Fetal Retinal Pigment Epithelium-Induced Apoptosis in Jurkat T Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3130 - 3134.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Sharma, N. Fatma, E. Kubo, T. Shinohara, L. T. Chylack Jr., and D. P. Singh
Lens Epithelium-derived Growth Factor Relieves Transforming Growth Factor-{beta}1-induced Transcription Repression of Heat Shock Proteins in Human Lens Epithelial Cells
J. Biol. Chem., May 23, 2003; 278(22): 20037 - 20046.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. D. Becker, S. R. Planck, S. Crespo, K. Garman, R. J. Fleischman, P. Dullforce, G. W. Seitz, T. M. Martin, D. C. Parker, and J. T. Rosenbaum
Immunohistology of Antigen-Presenting Cells In Vivo: A Novel Method for Serial Observation of Fluorescently Labeled Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2004 - 2009.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. Reinhard, H. Bonig, S. Mayweg, D. Bohringer, U. Gobel, and R. Sundmacher
Soluble Fas Ligand and Transforming Growth Factor {beta}2 in the Aqueous Humor of Patients With Endothelial Immune Reactions After Penetrating Keratoplasty
Arch Ophthalmol, December 1, 2002; 120(12): 1630 - 1635.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
S Saika, T Miyamoto, I Ishida, K Shirai, Y Ohnishi, A Ooshima, and J W McAvoy
TGF{beta}-Smad signalling in postoperative human lens epithelial cells
Br. J. Ophthalmol., December 1, 2002; 86(12): 1428 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. C. McKenna, Y. Xu, and J. A. Kapp
Injection of Soluble Antigen into the Anterior Chamber of the Eye Induces Expansion and Functional Unresponsiveness of Antigen-Specific CD8+ T Cells
J. Immunol., November 15, 2002; 169(10): 5630 - 5637.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. Namba, N. Kitaichi, T. Nishida, and A. W. Taylor
Induction of regulatory T cells by the immunomodulating cytokines {alpha}-melanocyte-stimulating hormone and transforming growth factor-{beta}2
J. Leukoc. Biol., November 1, 2002; 72(5): 946 - 952.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. S. Gregory, A. C. Repp, A. M. Holhbaum, R. R. Saff, A. Marshak-Rothstein, and B. R. Ksander
Membrane Fas Ligand Activates Innate Immunity and Terminates Ocular Immune Privilege
J. Immunol., September 1, 2002; 169(5): 2727 - 2735.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Takase, S. Sugita, D. J. Rhee, Y. Imai, C. Taguchi, Y. Sugamoto, Y. Tagawa, J. Nishihira, P. Russell, and M. Mochizuki
The Presence of Macrophage Migration Inhibitory Factor in Human Trabecular Meshwork and its Upregulatory Effects on the T Helper 1 Cytokine
Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2691 - 2696.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader
Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis
J. Immunol., August 1, 2002; 169(3): 1561 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
V. B. Mahajan, C. Wei, and P. J. McDonnell III
Microarray Analysis of Corneal Fibroblast Gene Expression after Interleukin-1 Treatment
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2143 - 2151.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. C. Joyce, D. L. Harris, and D. M. Mello
Mechanisms of Mitotic Inhibition in Corneal Endothelium: Contact Inhibition and TGF-{beta}2
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2152 - 2159.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
I. M. Wormstone, S. Tamiya, I. Anderson, and G. Duncan
TGF-{beta}2-Induced Matrix Modification and Cell Transdifferentiation in the Human Lens Capsular Bag
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2301 - 2308.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
S. Saika, T. Miyamoto, T. Tanaka, I. Ishida, Y. Ohnishi, and A. Ooshima
Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells
Br. J. Ophthalmol., November 1, 2001; 85(11): 1362 - 1366.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. E. Skelsey, J. Mellon, and J. Y. Niederkorn
{{gamma}}{{delta}}T Cells Are Needed for Ocular Immune Privilege and Corneal Graft Survival
J. Immunol., April 1, 2001; 166(7): 4327 - 4333.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-H. Sonoda, D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein
NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance
J. Immunol., January 1, 2001; 166(1): 42 - 50.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. M. Hales, C. G. Chamberlain, and J. W. McAvoy
Susceptibility to TGF{beta}2-Induced Cataract Increases with Aging in the Rat
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3544 - 3551.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
S. Sugita, C. Taguchi, H. Takase, K. Sagawa, J. Sueda, K. Fukushi, N. Hikita, T. Watanabe, K. Itoh, and M. Mochizuki
Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
Br. J. Ophthalmol., October 1, 2000; 84(10): 1130 - 1134.
[Abstract] [Full Text]

Home page
 IOVSHome page
K. Ohta, S. Yamagami, A. W. Taylor, and J. W. Streilein
IL-6 Antagonizes TGF-{beta} and Abolishes Immune Privilege in Eyes with Endotoxin-Induced Uveitis
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2591 - 2599.
[Abstract] [Full Text]

Home page
 IOVSHome page
T. Kezuka and J. W. Streilein
Analysis of In Vivo Regulatory Properties of T Cells Activated In Vitro by TGF{beta}2-Treated Antigen Presenting Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1410 - 1421.
[Abstract] [Full Text]

Home page
 IOVSHome page
M. F. Cordeiro, S. S. Bhattacharya, G. S. Schultz, and P. T. Khaw
TGF-{beta}1, -{beta}2, and -{beta}3 In Vitro: Biphasic Effects on Tenon’s Fibroblast Contraction, Proliferation, and Migration
Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 756 - 763.
[Abstract] [Full Text]

Home page
 IOVSHome page
M. Yoshida, M. Takeuchi, and W. Streilein
Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact
Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 811 - 821.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
W R MEACOCK, D J SPALTON, and M R STANFORD
Role of cytokines in the pathogenesis of posterior capsule opacification
Br. J. Ophthalmol., March 1, 2000; 84(3): 332 - 336.
[Full Text]

Home page
 J. Immunol.Home page
K. Ohta, B. Wiggert, S. Yamagami, A. W. Taylor, and J. W. Streilein
Analysis of Immunomodulatory Activities of Aqueous Humor from Eyes of Mice with Experimental Autoimmune Uveitis
J. Immunol., February 1, 2000; 164(3): 1185 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
L. Reneker, D. Silversides, L Xu, and P. Overbeek
Formation of corneal endothelium is essential for anterior segment development - a transgenic mouse model of anterior segment dysgenesis
Development, January 2, 2000; 127(3): 533 - 542.
[Abstract] [PDF]

Home page
 IOVSHome page
M. Tanigawa, J. E. Bigger, M. Y. Kanter, and S. S. Atherton
Natural Killer Cells Prevent Direct Anterior-to-Posterior Spread of Herpes Simplex Virus Type 1 in the Eye
Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 132 - 137.
[Abstract] [Full Text]

Home page
 JEMHome page
K.-H. Sonoda, M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein
CD1-reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site
J. Exp. Med., November 1, 1999; 190(9): 1215 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K.-H. Chen, D. L. Harris, and N. C. Joyce
TGF-{beta}2 in Aqueous Humor Suppresses S-Phase Entry in Cultured Corneal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2513 - 2519.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. F. Cordeiro, M. B. Reichel, J. A. Gay, F. D’Esposita, R. A. Alexander, and P. T. Khaw
Transforming Growth Factor-{beta}1, -{beta}2, and -{beta}3 In Vivo: Effects on Normal and Mitomycin C-Modulated Conjunctival Scarring
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1975 - 1982.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. H. Lee and C.-K. Joo
Role of Transforming Growth Factor-{beta} in Transdifferentiation and Fibrosis of Lens Epithelial Cells
Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2025 - 2032.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi
Pregnancy Ameliorates Induction and Expression of Experimental Autoimmune Uveitis
J. Immunol., March 1, 1999; 162(5): 2648 - 2654.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
R. S. Ayyala, L. E. Harman, B. Michelini-Norris, L. E. Ondrovic, E. Haller, C. E. Margo, and S. X. Stevens
Comparison of Different Biomaterials for Glaucoma Drainage Devices
Arch Ophthalmol, February 1, 1999; 117(2): 233 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
J. D O Pena, A. W Taylor, C. S Ricard, I. Vidal, and M R. Hernandez
Transforming growth factor beta  isoforms in human optic nerve heads
Br. J. Ophthalmol., February 1, 1999; 83(2): 209 - 218.
[Abstract] [Full Text]

Home page
 DevelopmentHome page
A. Meeson, M Argilla, K Ko, L Witte, and R. Lang
VEGF deprivation-induced apoptosis is a component of programmed capillary regression
Development, January 4, 1999; 126(7): 1407 - 1415.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
M. M. Kosiewicz, P. Alard, and J. W. Streilein
Alterations in Cytokine Production Following Intraocular Injection of Soluble Protein Antigen: Impairment in IFN-{gamma} and Induction of TGF-{beta} and IL-4 Production
J. Immunol., November 15, 1998; 161(10): 5382 - 5390.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. E. Bigger, C. A. Thomas III, and S. S. Atherton
NK Cell Modulation of Murine Cytomegalovirus Retinitis
J. Immunol., June 15, 1998; 160(12): 5826 - 5831.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Takeuchi, P. Alard, and J. W. Streilein
TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
J. Immunol., February 15, 1998; 160(4): 1589 - 1597.
[Abstract] [Full Text] [PDF]